FDA Approves Second Drug Designed to Help Evaluate for Alzheimer’s, Dementia – Nature World News


Nature World News

FDA Approves Second Drug Designed to Help Evaluate for Alzheimer's, Dementia
Nature World News
Called Vizamyl, the radioactive diagnostic drug works by attaching to the abnormal protein called beta amyloid, found in patients with Alzheimer's. A negative Vizamyl scan, therefore, suggests a person's cause of dementia is not Alzheimer's related ...
Sunflowers symbolize hope for Alzheimer's and DementiaKota
Alzheimer's disease prevention: What you need to know *****Food Consumer
New Tool for Dementia Evaluation Approved by FDAMonthly Prescribing Reference
HeraldNet -WNCN -TheChronicleHerald.ca
all 61 news articles »